Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-AnalysisFrancesco Schettini, Daniele Generali, Mariavittoria Locci et al.|Cancers|2021Cited by 35
Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast CancerFrancesco Schettini, Daniele Generali, Mario Giuliano et al.|Cancers|2021Cited by 19
Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical reviewFederica Miglietta, Valentina Guarneri, Alessandra Fabi et al.|Cancer Treatment Reviews|2023Cited by 13
Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus projectStefania Gori, Paolo Tralongo, Fiorenza De Rose et al.|Cancer Treatment Reviews|2024Cited by 2